2025 Pharmaceutical Digital Marketing Breakthrough: A Forum Addressing Core Pain Points in Compliance, Traffic, and Trust

Niu Zhengqian, Executive Vice President of the China Pharmaceutical Enterprise Management Association, will dissect the development trends of digital technologies in pharmaceutical marketing. Li Shaochun, Digital Strategy Scientist at Yunnan Baiyao Group, will reveal on-site the secrets behind AI becoming a strategic force in pharmaceutical R&D and marketing.

On the pharmaceutical marketing platform, three leading domestic digital pharmaceutical marketing enterprises—Knowledge Matrix, Health Road, and Huimei Digital Technology—will analyze the most advanced digital marketing models through real-world case studies, based on their respective business characteristics.

From the pharmaceutical company perspective, Bayer, Huahong Pharmaceutical, and Tasly analyzed market demands and engaged in a brainstorming session on the full-spectrum digital marketing value chain for pharmaceutical enterprises.

At this conference, pharmaceutical companies, digital marketing firms, pharmaceutical e-commerce platforms, and pharmacies will come together to accelerate resource collaboration and development in the pharmaceutical market.

Furthermore, VCBeat VBEF concurrently hosts a series of N+ activities, including closed-door meetings for government and enterprise representatives, promotion sessions for high-quality assets, and launch events for innovative products. By adopting an integrated “exhibition + forum + transaction” model, it facilitates deep connections between premium assets and global capital, local industrial chains, and end-user medical institutions, thereby helping China’s high-quality innovative healthcare and pharmaceutical assets bridge the gap from “innovation capability” to “productive capacity.”

The Exhibition Achieves Diversified Matchmaking:2025 VBEF Special Exhibition Area DesignCenter Stage (Themed Roadshows, Product Launches), Innovative Product Showcase (Product Demonstrations, Case Studies)、Innovative Assets Poster Exhibition (TOP 100 Investment Landscape, Resource Matchmaking)Three Major Value Domains: Accelerating the Value Fission of High-Quality Innovative Assets in China’s Healthcare and Pharmaceutical Industries Through Innovative Models and Efficient Mechanisms.

Forum Decoding Trends:2 Main Forums, 4 Featured Forums, and 20+ Thematic Forums comprehensively cover the hot sectors of high-quality innovative assets in China’s healthcare and pharmaceutical industries. Over 300 industry leaders, academicians, experts, and corporate executives discuss growth poles in China’s healthcare industry, precisely identifying growth drivers for high-quality assets.

High-Efficiency Transaction Scenarios:Exhibiting companies can engage directly with international buyers, overseas distributors, and supply chain partners. Through on-site negotiations and demand-matching sessions, they can swiftly secure business opportunities in cross-border cooperation, technology introduction, and product distribution, thereby facilitating the integration of China’s high-quality innovative medical and pharmaceutical assets into the global industrial chain.